Lumbar Discectomy Control Study, Risk Factors for Reherniation
A Prospective, Multicenter Study Investigating Reherniation Risk Factors and Associated Costs in Primary Lumbar Disc Herniation Patients
Sponsor: Intrinsic Therapeutics
A observational or N/A phase clinical study on Lumbar Spine Disc Herniation, this trial is ongoing. The trial is conducted by Intrinsic Therapeutics and has accumulated 18 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
18 versions recorded-
Nov 2025 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
Feb 2022 — Oct 2023 [monthly]
Active Not Recruiting
▶ Show 13 earlier versions
-
Jun 2021 — Feb 2022 [monthly]
Active Not Recruiting
-
Apr 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Mar 2020 — Sep 2020 [monthly]
Active Not Recruiting
-
Sep 2019 — Mar 2020 [monthly]
Active Not Recruiting
-
Jul 2019 — Sep 2019 [monthly]
Active Not Recruiting
-
Mar 2019 — Jul 2019 [monthly]
Active Not Recruiting
-
Nov 2018 — Mar 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Intrinsic Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .